{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T12:28:37Z","timestamp":1714048117633},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jocn.2014.12.027","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T19:11:09Z","timestamp":1432149069000},"page":"1123-1127","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke"],"prefix":"10.1016","volume":"22","author":[{"given":"Ping","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Wo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng-guang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-ming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2014.12.027_b0005","first-page":"1","article-title":"Thrombolysis in acute ischemic stroke: issues and options","volume":"43","author":"Lou","year":"2014","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jocn.2014.12.027_b0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000365210","article-title":"Stroke unit management and revascularisation in acute ischemic stroke","volume":"73","author":"Jung","year":"2015","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2014.12.027_b0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.jocn.2014.12.027_b0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MBC.0b013e328346f8ca","article-title":"The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria","volume":"22","author":"Chud\u00fd","year":"2011","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.jocn.2014.12.027_b0025","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3346\/jkms.2012.27.7.803","article-title":"Impact of lysophosphatidylcholine on the plasminogen activator system in cultured vascular smooth muscle cells","volume":"27","author":"Yoon","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jocn.2014.12.027_b0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/eurheartj\/ehq444","article-title":"Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients","volume":"32","author":"Kario","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jocn.2014.12.027_b0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/01.STR.32.6.1341","article-title":"Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion","volume":"32","author":"Hosomi","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2014.12.027_b0145","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/jcbfm.2014.99","article-title":"Plasmin-dependent modulation of the blood\u2013brain barrier: a major consideration during tPA-induced thrombolysis?","volume":"34","author":"Niego","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jocn.2014.12.027_b0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000296282","article-title":"A biochemical study on the effect of proteolysis of beta-thromboglobulin proteins released from activated platelets on fibroblast proliferation","volume":"36","author":"Ravindran","year":"2007","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.jocn.2014.12.027_b0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.STR.14.4.518","article-title":"Usefulness of the measurement of plasma beta-thromboglobulin (beta-TG) in cerebrovascular disease","volume":"14","author":"Taomoto","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2014.12.027_b0055","first-page":"429","article-title":"Hemostatic markers of endothelial injury in ischaemic stroke caused by large or small vessel disease","volume":"21","author":"Iskra","year":"2006","journal-title":"Pol Merkur Lekarski"},{"key":"10.1016\/j.jocn.2014.12.027_b0060","first-page":"E11","article-title":"Stroke biomarkers: can they help us to guide stroke thrombolysis?","volume":"11","author":"Montaner","year":"2007","journal-title":"Timely Top Med Cardiovasc Dis"},{"key":"10.1016\/j.jocn.2014.12.027_b0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1253\/jcj.64.547","article-title":"Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction","volume":"64","author":"Soeki","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jocn.2014.12.027_b0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2298\/MPNS0806247V","article-title":"Influence of fibrinolitic potential reduction in ischemic brain disease development","volume":"61","author":"Vuckovi\u0107","year":"2008","journal-title":"Med Pregl"},{"key":"10.1016\/j.jocn.2014.12.027_b0075","first-page":"163","article-title":"Determination of plasma tissue type plasminogen activator and its inhibitor activity","volume":"12","author":"Wang","year":"1989","journal-title":"Chin J Lab Med"},{"key":"10.1016\/j.jocn.2014.12.027_b0080","first-page":"98","article-title":"\u03b2-TG RIA and clinical application","volume":"5","author":"Shi","year":"1985","journal-title":"Chin J Nucl Med"},{"key":"10.1016\/j.jocn.2014.12.027_b0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejim.2012.04.007","article-title":"Mean platelet volume and \u03b2-thromboglobulin levels in familial mediterranean fever: effect of colchicine use?","volume":"23","author":"Abanonu","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jocn.2014.12.027_b0090","first-page":"312","article-title":"PAI-1 antagonists: the promise and the peril","volume":"122","author":"Vaughan","year":"2011","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.jocn.2014.12.027_b0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1254\/jphs.10R27FM","volume":"116","author":"Suzuki","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jocn.2014.12.027_b0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000175766","article-title":"Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients?","volume":"27","author":"Lou","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2014.12.027_b0105","first-page":"215","article-title":"Significance of vitronectin and PAI-1 activity levels in carotid artery disease: comparison of symptomatic and asymptomatic patients","volume":"104","author":"Ekmek\u00e7i","year":"2013","journal-title":"Minerva Med"},{"key":"10.1016\/j.jocn.2014.12.027_b0110","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuron.2006.04.013","article-title":"Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity","volume":"50","author":"Samson","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.jocn.2014.12.027_b0115","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1172\/JCI200319212","article-title":"Tissue-type plasminogen activator induces opening of the blood\u2013brain barrier via the LDL receptor-related protein","volume":"112","author":"Yepes","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocn.2014.12.027_b0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/83358","article-title":"The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling","volume":"7","author":"Nicole","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jocn.2014.12.027_b0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/00207451003597169","article-title":"PAI-1 4G\/5G polymorphism is associated with brain vessel reocclusion after successful fibrinolytic therapy in ischemic stroke patients","volume":"120","author":"Fernandez-Cadenas","year":"2010","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jocn.2014.12.027_b0130","first-page":"219","article-title":"Therapeutic approaches to vascular protectionin ischemic stroke","volume":"65","author":"Yamashita","year":"2011","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jocn.2014.12.027_b0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/00365513.2011.558106","article-title":"Platelet depletion, platelet activation and coagulation during treatment with hemodialysis","volume":"71","author":"Schoorl","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jocn.2014.12.027_b0140","first-page":"74","article-title":"Study on the relationship between plasmic \u03b2-TG, PF4 levels and hemorheology in gerontal patients with the insufficiency of Qi and stagnation of blood","volume":"21","author":"Sun","year":"2007","journal-title":"J Pract Tradition Chin Int Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T13:25:16Z","timestamp":1537622716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586815000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0967586815000764"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2014.12.027","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2014.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}